RGI
ELV icon

River Global Investors’s Elevance Health ELV Stock Holding History

River Global Investors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,880
Closed -$1.36M – 203
2023
Q4 		$1.36M Sell
2,880
-120
-4% -$55.5K 0.26% 123
2023
Q3 		$1.31M Buy
+3,000
New +$1.36M 0.31% 95

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

River Global Investors's ELV Position: Q1 2024 in Review

River Global Investors sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 2,880 shares — an estimated $1.36M sold.

River Global Investors first reported a position in ELV in Q3 2023 and held it in 2 quarters. The position peaked at $1.36M in Q4 2023. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • River Global Investors reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • River Global Investors sold 2,880 Elevance Health shares in Q1 2024, an estimated $1.36M.
  • River Global Investors first reported a position in Elevance Health in Q3 2023 and held it in 2 quarters.
  • River Global Investors's Elevance Health position peaked at $1.36M in Q4 2023.
  • 1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on River Global Investors's 13F filing for Q1 2024, filed 7 May 2024.